Page last updated: 2024-09-03

glicentin and Non-alcoholic Fatty Liver Disease

glicentin has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anastasilakis, AD; Boutari, C; Ghaly, W; Karagiannis, A; Kountouras, J; Mantzoros, CS; Perakakis, N; Polyzos, SA	1

Other Studies

1 other study(ies) available for glicentin and Non-alcoholic Fatty Liver Disease

Article	Year
Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. The Journal of clinical endocrinology and metabolism, 2020, 03-01, Volume: 105, Issue:3 Topics: Adult; Biomarkers; Biopsy; Case-Control Studies; Disease Progression; Female; Follistatin-Related Proteins; Glicentin; Glucose Tolerance Test; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Proglucagon; Severity of Illness Index; Somatomedins	2020

Article

Year

Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.

The Journal of clinical endocrinology and metabolism, 2020, 03-01, Volume: 105, Issue:3

Topics: Adult; Biomarkers; Biopsy; Case-Control Studies; Disease Progression; Female; Follistatin-Related Proteins; Glicentin; Glucose Tolerance Test; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Proglucagon; Severity of Illness Index; Somatomedins

2020